-
NCI study outlines opportunities to achieve President Biden’s Cancer Moonshot goal of reducing cancer death rates in the United States
Mon, Apr 17 2023
A new study has outlined opportunities for achieving President Biden and First Lady Biden’s Cancer Moonshot goal of reducing the cancer death rate by at least 50% over the next 25 years.
-
Pragmatica-Lung Study, a streamlined model for future cancer clinical trials, begins enrolling patients
Wed, Apr 12 2023
NCI has helped launch the Pragmatica-Lung Study, a phase 3 randomized clinical trial of a two-drug combination to treat patients with advanced non-small cell lung cancer. The simplified trial design aims to increase accessibility for participants.
-
NCI study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis
Tue, Apr 04 2023
An NCI study shows that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.
-
Cancer Grand Challenges announces global research funding opportunity with nine new challenges
Wed, Mar 08 2023
As part of the Cancer Grand Challenges program, NCI and Cancer Research UK have announced nine new research challenges to tackle profound problems in cancer research.
